Jiangsu Kanion Pharmaceutical Co Ltd - Class A

SHSE:600557 (China)   Class A
Â¥ 18.87 (+1.89%) Apr 24
20.51
P/B:
2.07
Market Cap:
Â¥ 11.03B ($ 1.52B)
Enterprise V:
Â¥ 9.37B ($ 1.29B)
Volume:
7.06M
Avg Vol (2M):
10.87M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Jiangsu Kanion Pharmaceutical Co Ltd ( SHSE:600557 ) from 2002 to Apr 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Jiangsu Kanion Pharmaceutical stock (SHSE:600557) PE ratio as of Apr 24 2024 is 20.51. More Details

Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) PE Ratio (TTM) Chart

To

Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) PE Ratio (TTM) Historical Data

Total 1175
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Jiangsu Kanion Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-24 20.5 2024-02-21 19.2
2024-04-24 20.5 2024-02-20 19.2
2024-04-23 20.1 2024-02-19 18.9
2024-04-22 20.2 2024-02-16 19.4
2024-04-19 20.6 2024-02-09 19.4
2024-04-18 20.3 2024-02-08 19.4
2024-04-17 20.5 2024-02-07 18.3
2024-04-16 20.1 2024-02-06 16.8
2024-04-15 20.8 2024-02-05 15.3
2024-04-12 23.1 2024-02-02 16.0
2024-04-11 22.7 2024-02-01 16.9
2024-04-10 22.8 2024-01-31 17.1
2024-04-09 22.7 2024-01-30 18.1
2024-04-08 22.0 2024-01-29 19.4
2024-04-05 22.8 2024-01-26 19.1
2024-04-03 22.8 2024-01-25 19.4
2024-04-02 22.9 2024-01-24 19.6
2024-04-01 23.5 2024-01-23 19.8
2024-03-29 22.5 2024-01-22 19.6
2024-03-28 23.0 2024-01-19 21.1
2024-03-27 23.4 2024-01-18 21.6
2024-03-26 23.4 2024-01-17 21.8
2024-03-25 23.3 2024-01-16 21.6
2024-03-22 24.0 2024-01-15 21.8
2024-03-21 24.5 2024-01-12 20.9
2024-03-20 25.0 2024-01-11 21.3
2024-03-19 25.0 2024-01-10 21.9
2024-03-18 26.2 2024-01-09 22.8
2024-03-15 24.3 2024-01-08 22.7
2024-03-14 24.0 2024-01-05 23.5
2024-03-13 23.3 2024-01-04 23.9
2024-03-12 23.5 2024-01-03 24.0
2024-03-11 22.7 2024-01-02 23.1
2024-03-08 20.6 2023-12-29 22.6
2024-03-07 20.0 2023-12-28 21.9
2024-03-06 20.4 2023-12-27 23.6
2024-03-05 20.7 2023-12-26 23.3
2024-03-04 21.4 2023-12-25 24.0
2024-03-01 19.7 2023-12-22 23.9
2024-02-29 19.5 2023-12-21 25.1
2024-02-28 19.2 2023-12-20 25.1
2024-02-27 19.8 2023-12-19 24.2
2024-02-26 19.6 2023-12-18 24.4
2024-02-23 19.6 2023-12-15 23.7
2024-02-22 19.4 2023-12-14 24.1

Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Jiangsu Kanion Pharmaceutical Co Ltd focuses on R&D, production and trade of traditional Chinese medicine. The company also makes orthopedics, cardiovascular, anti-infective and anti-tumor products.